Some researchers have used a small molecule inhibitor, N6-(1-iminoethyl)-L-lysine (L-NIL), to target iNOS to achieve tumor regression (Jenkins et al., 1995; Zhang and Xu, 2001; Fukumura et al., 2006; Jayaraman et al., 2012). This evidence concerns the gene NOS2 and neoplasm.